PCLAF and cancer: However, a recent study demonstrated that PAFAH1B3 knockdown did not change PAF levels or PAFAH hydrolytic activity, indicating that the impact of PAFAH1B3-mediated cancer pathogenicity may not depend on PAF signaling pathways (11).